FDA Withdraws Final Rule Regulating Lab-Developed Tests as Medical Devices
The action follows a federal court order that vacated the 2024 rule, reinstating FDA’s prior policy of enforcement discretion for laboratory-developed tests.
Read MorePosted by Alyx Arnett | Sep 22, 2025 | Compliance |
The action follows a federal court order that vacated the 2024 rule, reinstating FDA’s prior policy of enforcement discretion for laboratory-developed tests.
Read MorePosted by Alyx Arnett | Sep 22, 2025 | Compliance |
AdvaMed urges inclusion of diagnostic tests in legislation that would provide four years of coverage for FDA-designated breakthrough technologies.
Read MorePosted by CLP Edit Staff | Sep 18, 2025 | Compliance |
Settlement resolves False Claims Act litigation alleging illegal payments disguised as management service organization distributions.
Read MorePosted by CLP Edit Staff | Sep 17, 2025 | Middleware & Software |
The tool provides real-time support for experiment troubleshooting, protocol optimization, and data analysis within the existing workflow.
Read MorePosted by CLP Edit Staff | Sep 16, 2025 | Lab Automation |
The vendor-neutral platform is designed to connect instruments, robotics, and enterprise systems to improve throughput and compliance.
Read More